The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
my thought is the kind of a the kind of evaluation that you do routinely of your patients if we took a group of 65 year olds and we gave them a drug that we thought was an anti-aging drug and follow them the next five or six years doing these evaluations I think you could probably safely say this is slowing aging or slowing not or not slowing aging
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.